Classical Hodgkin lymphoma Header
opdivo-dtc-util-nav

Indications

Prescribing Information

Next Page Icon

Medication Guide

Next Page Icon
Potential OPDIVO® (nivolumab) user taking a selfie with her partner.
Potential OPDIVO® (nivolumab) user taking a selfie with her partner.

Your fight against classical
Hodgkin lymphoma
may
continue here

OPDIVO is an FDA-approved immunotherapy option for previously treated classical Hodgkin lymphoma

Actor portrayals.

Previously treated classical Hodgkin lymphoma

OPDIVO is a treatment option for certain adults with previously treated classical Hodgkin lymphoma whose cancer has come back or spread

OPDIVO will not work for everyone. Individual results may vary.

Man exploring real patients stories of experiences with OPDIVO® (nivolumab) or other OPDIVO-based combinations.

Patient stories

Real patients share their experiences with OPDIVO and OPDIVO-based treatments

Frequently asked questions about treatment with OPDIVO® (nivolumab).

Have questions about treatment?

We have answers about infusions, monitoring, and more

Hands exploring cost information and financial help for OPDIVO® (nivolumab).

Cost information and financial help

Find information about cost and access to OPDIVO